RBC Life Sciences Inc. reported unaudited earnings results for the first quarter ended March 31, 2014. For the quarter, the company reported consolidated net sales of $5,713,000 against $5,691,000 which was flat compared to the first quarter of 2013. The company reported operating loss of $492,000 compared to operating profit of $23,000 a year ago.

Loss before income taxes was $518,000 compared to $6,000 a year ago. Net loss was $378,000 compared to $8,000 a year ago. Loss per diluted share was $0.17.

Net sales of Nutritional Products during the first quarter decreased by approximately 5%, due to decreased shipments to international licensees.